Axel Bitblaze
Altcoin & Memecoin Commentary
Injective could attract repeat traders and generate fees to support INJ buybacks and burns as it adds markets and trading tools. SICI is live for trading GPU rental prices; options for SICI, US indexes and commodities are on testnet, and developers can build options apps on the same infrastructure. BDACS is working to bring KRW1 settlement to its RWA markets, subject to regulatory approval. INJ deserves a place on the watchlist. x.comÂ
Injective's tokenization and confidential-DeFi activity will create onchain revenue to fund monthly INJ buybacks and burns. POSCO and LG CNS tested tokenizing real-sales receivables; Gulf Labs runs a validator and is exploring tokenization and stablecoins. Mint's private beta adds ownership and transfer rules, while CypherOS was previewed for confidential transfers, trading and tokenization. That puts INJ high on the dip watchlist. x.comÂ
Injective's Meridian mainnet upgrade is the upgrade that sends INJ to $20. Per @NinjaCatSF, it brings better support for tokenized real-world assets, smoother trading across the Injective ecosystem, stronger market infrastructure and groundwork for private institutional trading. INJ feels like Near before its hype, with the vision coming together. x.com x.comÂ
Injective faces no large early-investor unlock that could add selling pressure over the long term. All of its token supply is already circulating, with market cap equal to fully diluted value; that makes holding it a healthier long-term proposition than RWA layer-1 tokens with an unlock cliff. x.com x.comÂ
Injective's INJ is no longer attractive enough to compete with newer Layer 1 projects, in reply to @DukeD_Defi's case that the market misprices it as an onchain capital-markets chain. x.comÂ
Injective looks primed to 2x or even 3x in a relatively short period, and 100% of its supply is already in circulation. x.com x.comÂ
Mid-cap layer-1 tokens Sui, Aptos, NEAR and Injective show strong recovery potential as capital rotates from bitcoin and ether into mid-cap L1s, a gradual rerating on real fundamentals, not a 2021-style pump. Sui has TVL above ~$745M and ~954 monthly active developers; Aptos has parallel execution and dev traction; NEAR logged ~314M Q1 transactions despite slowing activity; Injective launched real-time USDC settlement. Every bull cycle needs strong L1 activity, so L1s should move together soon. … Show more
Intercontinental Exchange, CME Group and Cboe are in the first inning of a de-rating, as the rush to defend them against crypto perpetual futures competition shows. With few near-term catalysts to make them work, they are worth revisiting in 12-24 months. x.comÂ
io.net ties its token to real revenue, which matters more than partnerships or famous logos. It earns $12.3M in annualized revenue, one of the highest in DePIN, and its new Incentive Dynamic Engine links token burns to network revenue instead of fixed emissions. At least half of net revenue is burned, and io.net expects to remove at least 12 million tokens from circulation over the next year. At this stage, token prices are still driven more by market sentiment than fundamentals. x.com x.com … Show more
Coinbase should recover into a more diversified business when bitcoin recovers, yet it trades as if its only product broke. In nine months it added zero-commission stock trading, prediction markets at $100M annualized revenue, stock and pre-IPO perps, and derivatives at $200M annualized, and it receives about 50% of USDC economics. Bitcoin near $64K sits below its ~$87K mining cost, historically a buy signal. At 6-7x sales versus Robinhood's 18.6x, the risk/reward is favorable. x.comÂ
